Yiwei Xiaoyu granules for treatment of chronic atrophic gastritis with deficiency syndrome of the spleen and stomach

BACKGROUND The Correa sequence,initiated by Helicobacter pylori(H.pylori),commonly progresses to gastric cancer through the stage of chronic atrophic gastritis(CAG).Although eradication of H.pylori only reduces the risk of gastric cancer,it does not eliminate the risk for neoplastic progression.Yiwei Xiaoyu granules(YWXY)are a commonly used composite preparation in Chinese clinics.However,the pursuit of excellence in clinical trials and the establishment of standardized animal experiments are still needed to contribute to full understanding and application of traditional Chinese medicine in the treatment of CAG.AIM To demonstrate the effectiveness of YWXY in patients with CAG and spleenstomach deficiency syndrome(DSSS),by alleviating histological scores,improving response rates for pathological lesions,and achieving clinical efficacy in relieving DSSS symptoms.METHODS We designed a double-blind,randomized,controlled trial.The study enrolled seventy-two H.pylori-negative patients(mean age,52.3 years;38 men)who were randomly allocated to either the treatment group or control group in a 1:1 ratio,and treated with 15 g YWXY or 0.36 g Weifuchun(WFC)tablet combined with the respective dummy for 24 wk.The pre-randomization phase resulted in the exclusion of 72 patients:50 participants did not meet the inclusion criteria,12 participants declined to participate,and 10 participants were excluded for various other reasons.Seven visits were conducted during the study,and histopathological examination with target endoscopic biopsy of narrow-band imaging was requested before the first and seventh visits.We also evaluated endoscopic performance scores,total symptom scores,serum pepsinogen and gastrin-17.RESULTS Six patients did not complete the trial procedures.Treatment with YWXY improved the Operative Link on Gastric Intestinal Metaplasia Assessment(OLGIM)stage,compared with WFC(P<0.05).YWXY provided better relief from symptoms of DSSS and better improvement in serum gastric function,compared with WFC(P<0.05).CONCLUSION YWXY compared with WFC significantly reduced the risk of mild or moderate atrophic disease,according to OLGIM stage,significantly relieved symptoms of DSSS,and improved serum gastric function.

Effect of Western medicine therapy assisted by Ginkgo biloba tablet on vascular cognitive impairment of none dementia

Objective:To discuss the clinical effects of Western medicine therapy assisted by Ginkgo biloba tablet(GBT) on patients with vascular cognitive impairment of none dementia(VCIND).Methods: A total of 80 patients with VCIND were divided into two groups randomly:Conventional treatment group(control group) and combined treatment group.Conventional treatment group was given conventional treatment with anti-platelet aggregation.In this group,75 mg aspirin was given three times a day for 3 months.While in combined treatment group,19.2 mg CRT was given three times a day for 3 months together with conventional treatment(anti-platelet aggregation drugs). Montreal cognitive assessment(MoCA) and transcranial Doppler(TCD) were used to observe changes of cognitive ability and cerebral blood flow in VCIND patients before and after treatment in both groups.Then the clinical data were analyzed so as to compare the efficacy in two groups. Results:After 3 month-treatment in combined treatment group,the scores of executive ability, attention,abstract,delayed memory,orientation in the MoCA were significantly increased compared with those before treatment and those in control group after treatment.Besides,blood flow velocity of anterior cerebral artery increased significandy than that before treatment and that in control group after treatment.Conclusions:CBT tablet can improve the therapeutic efficacy as well improve cognitive ability and cerebral blood flow supply of patients with VCIND.

Hepar Fule Tablets——Chinese Traditional Medicine for Antihepatic Cancer

Hepar Fule tablets, approved by the Ministry of Public Health. are produced solely by the Lengshijiang Medicine Factory, Hunan province. They were invented by Doctor Pan Minqiu, a famous expert in hepatic diseases and cancer, after a dozen years’ painstaking research. They are made, based on a reasonable prescription, advanced technology and strict quality control from 21 Chinese medicines, including radix codonopsis pilosulae,

Clinical efficacy and safety of Guipi decoction combined with escitalopram oxalate tablets in patients with depression

BACKGROUND Depression is a widespread mental health condition that requires effective treatment.In the treatment of depression,traditional Chinese medicine(TCM)offers obvious advantages,fewer adverse reactions,and a lower recurrence rate.AIM To evaluate the clinical benefits of Guipi decoction combined with escitalopram oxalate tablets for individuals with depression.METHODS In total,80 patients diagnosed as having depression were enrolled in the study and divided into either an experimental group or a control group.All of the patients were orally administered escitalopram oxalate tablets.Additionally,the experimental group received Jiajian Guipi decoction and reduced Governor vessel fumigation over 4 wk.TCM syndrome scores,Hamilton depression rating scale(HAM-D)scores,self-rating depression scale(SDS)scores,and Pittsburgh sleep quality index scores were measured for the two groups and compared before and after the treatment.The two groups were monitored for any adverse reactions.RESULTS After 4 wk of treatment,both groups exhibited a significant reduction in TCM syndrome scores compared with their pre-treatment scores(P<0.05).However,the experimental group exhibited significantly lower TCM syndrome scores than the control group(P<0.05).Similarly,the post-treatment SDS and HAM-D-24 scores were significantly lower in both groups than the pre-treatment scores(P<0.05),with the experimental group exhibiting lower scores than the control group(P<0.05).The total treatment efficiency was significantly better in the experimental group(97.14%)than in the control group(77.78%)(P<0.05).Furthermore,after 4 wk of treatment,the Pittsburgh sleep quality index scores for both groups were significantly lower than those before the treatment(P<0.05),with the experimental group exhibiting lower scores than the control group(P<0.05).The incidence of adverse reactions was significantly lower in the experimental group than in the control group(P<0.05).CONCLUSION The combination of Guipi decoction and escitalopram oxalate tablets was found to be an effective and safe treatment for depression.This combination could reduce TCM syndrome scores,improve depressive symptoms,and enhance sleep quality.

Clinical Study on Treatment of Chronic Prostatitis with Lingze Tablets Combined with TCM Herbal Acupoint Plasters

Objective:To study the therapeutic effect of Lingze tablets combined with traditional Chinese medicine herbal acupoint plasters on chronic prostatitis.Methods:A total of 64 patients with chronic prostatitis who were admitted to the Andrology Clinic of Shuyang County Hospital of Traditional Chinese Medicine from March 2021 to March 2023 were randomly divided into a treatment group and a control group,with 32 cases in each group.The control group took Lingze tablets orally,4 tablets/time,3 times/d;the treatment group took the same medication along with traditional Chinese medicine acupoint herbal plasters.The two groups of patients were treated continuously for 6 weeks,and the differences in the relevant indexes of the curative effect were observed.Results:The NIH-Chronic Prostatitis Symptom Index(NIH-CPSI)scores of the two groups significantly reduced after treatment(P<0.05),and the scores of the patients in the treatment group were lower than those in the control group(P<0.05).The treatment received in the treatment group achieved and efficacy of 96.88%,which was significantly higher than that of the group,which was 81.25%(P<0.05).The maximum flow rate(MFR),average flow rate AFR,and urine output of the patients of both groups improved significantly after treatment(P<0.05).However,the experimental group showed better improvements in these indicators(P<0.05).Conclusion:Lingze tablets combined with traditional Chinese medicine acupoint herbal plasters can significantly improve the symptoms and urodynamic function of patients with chronic prostatitis.

Retrospective Analysis and Summary on Efficacy of Jianpi Shengxue Tablet in the Treatment of Iron Deficiency Anemia

[Objectives]The research aimed to make a retrospective analysis and summary on the efficacy of Jianpi Shengxue Tablet in the treatment of iron deficiency anemia.[Methods]A total of 200 patients with iron deficiency anemia who were treated at outpatient in Tongzhou District of Dongzhimen Hospital of Beijing University of Chinese Medicine from January 1,2017 to October 30,2020 were selected as the research objects.All these patients were given treatment with Jianpi Shengxue Tablet for the first time.Results of blood routine examination,serum iron concentration,total iron binding capacity and ferritin were compared before and after treatment at different dates.Subjective symptoms and adverse reactions were also described.Jianpi Shengxue Tablet was given orally after meals,3 tablets each time,3 times a day.[Results]Hemoglobin level was(83.58±15.81)g/L(M±SD,n=200)before treatment,and(103.40±12.60)g/L(n=74)after 2 week's treatment,with a 24.3%increase(P=0.0047).Hemoglobin concentration was(111.9±19.4)g/L(n=47)at the 4th week after treatment,which was near normality;(126.0±9.49)g/L(n=30)at the 6th week with complete normality and(130.7±7.95)g/L(n=23)at the 8th week.MCV,MCH and MCHC increased gradually after treatment.Serum total iron biding capacity decreased,while serum iron and ferritin increased gradually,and the three indexes were significantly different at the 4th week after treatment as compared with those before treatment(P﹤0.01).Subjective symptoms were improved in the 1st week from starting treatment among all the cases.The adverse events were mainly gastrointestinal irritation,occurring in 7/200 cases(3.5%).[Conclusions]Jianpi Shengxue Tablet is quite effective and safe in the treatment of iron deficiency anemia,with rapid comprehensive improvement of anemia-related symptoms and increase of hemoglobin and red blood cell parameters.

Differential Treatment for Membranoproliferative Glomerulonephritis with TCM Prescriptions Plus Triptoryph Tablets A Report of 30 Cases

Membranoproliferative glomerulonephritis is aglomerulopathy,which accounts for about 30% of thechronic glomerulonephritis in adults.TCMmedication with addition of triptoryph tablets(Tripterygium Wilfordii polyglycosidium) on thebasis of syndrome differentiation had yieldedsatisfactory results in 30 cases of this disease treatedfrom Jan 1998 to Aug 2002.A report follows.

Metabolomic profiling reveals hypoglycemic effect of Jinqi Jiangtang tablet on type 2 diabetic rats

Background:Si-Miao Sun wrote about the Jinqi Jiangtang tablet(JQJT)that is derived from the traditional Chinese herbal medicine Huanglian(Coptis Chinensis Franch)pills in the Essential Recipes for Emergent Use Worth A Thousand Gold in C.E.652.The tablet is used to treat diabetes in China owing to its powerful hypoglycemic properties.However,little is known about the metabolic mechanisms underlying these properties.Methods:Ultra-high-performance liquid chromatography coupled with quadrupole-time-of-flight tandem mass spectrometry-based metabolomics approach was performed to explore the metabolic mechanism of JQJT in the treatment of type 2 diabetes mellitus(T2DM).Results:The metabolomic pathway analysis and the Kyoto Encyclopedia of Genes and Genomes database were used to screen out 25 potential biomarkers and construct pertinent metabolic pathways.Five metabolites,such as allantoic acid and taurine,were downregulated and 20 metabolites were upregulated in the urine of T2DM rats.The biomarkers in the JQJT group exhibited a good callback trend.It is speculated that JQJT can alleviate T2DM by regulating the disorders of taurine,hypotaurine,phenylalanine,ascorbate,and aldarate metabolism,as well as pentose and glucuronate interconversions.Conclusion:This study will be meaningful in the clinical application of JQJT and will be valuable for further exploration of the metabolic mechanisms underlying its properties.

凉血十味片联合硝苯地平缓释片治疗原发性高血压性视网膜病变临床观察

目的探究凉血十味片联合硝苯地平缓释片治疗原发性高血压性视网膜病变(HR)的疗效及安全性。方法选取HR患者100例,按照随机数字表法分为治疗组(凉血十味片+硝苯地平缓释片)及对照组(硝苯地平缓释片),各50例,对比2组临床疗效。结果治疗组总有效率高于对照组(P<0.05);治疗后,治疗组血压、视力、眼底改变情况、眼底荧光素血管造影情况、中医证候积分均优于对照组(P<0.05)。结论凉血十味片联合硝苯地平缓释片治疗HR疗效确切,能有效提升患者视力,提高患者视觉质量,且无不良反应,安全有效。

Identification and determination of major constituents in a traditional Chinese medicine compound recipe Xiongdankaiming tablet using HPLC-PDA/ESI-MS^n and HPLC-UV/ELSD

Xiongdankaiming tablet (XDKMT), a well-known compound in traditional Chinese medicine, is widely used for the treatment of acute iridocyclitis and primary open-angle glaucoma. In this paper, accurate and reliable methods were developed for the identification of 20 constituents using high-performance liquid chromatography with photodiode array and electron spray ionization-mass spectrometry (HPLC-PDA/ESI-MSn ), and determination of nine of the constituents (chlorogenic acid, gentiopicroside, isochlorogenic acid B, diosmetin-7-O-β-D-glucopyranoside, apigenin, diosmetin, tauroursodeoxycholic acid, acacetin, and taurochenodeoxycholic acid) was developed using HPLC with ultraviolet absorption detector and evaporative light scattering detector (HPLC-UV/ELSD) for the first time. The best results were obtained on a Zorbax SB-C18 column with gradient elution using water (0.1% formic acid) (A) and methanol (0.1% formic acid) (B) at a flow rate of 0.7 ml/min. Tauroursodeoxycholic acid and taurochenodeoxycholic acid, owing to their low UV absorption, were detected by ELSD. The other seven compounds were analyzed by HPLC-UV with variable wavelengths. The calibration curves of all nine constituents showed good linear regression (R2 >0.9996) within the linearity ranges. The limits of detection and quantification were in the ranges of 0.0460-9.90 μg/ml and 0.115-24.8 μg/ml, respectively. The accuracy, in terms of recovery, varied from 95.3% to 104.9% with relative standard deviations (RSDs) less than 4.4%. Precision (with the intra- and inter-day variations less than 4.4%) was also suitable for its intended use. The developed method was successfully applied for the analysis of major components in XDKMT, which provides an appropriate method for the quality control of XDKMT.

瑞格列奈片联合加味肾气丸治疗阴阳两虚型2型糖尿病临床观察

目的分析瑞格列奈片联合加味肾气丸对2型糖尿病阴阳两虚型患者的治疗效果。方法纳入2020年10月—2021年10月山东省枣庄市薛城区人民医院100例阴阳两虚型2型糖尿病患者进行探究,以单双号方式分两组,对照组使用常规治疗和瑞格列奈片治疗,观察组在此基础上联合加味肾气丸。通过症状积分观察两组疗效,并对比其血糖和临床指标。结果治疗后,观察组空腹血糖、餐后2 h血糖、糖化血红蛋白数据低于对照组(P<0.05);观察组血清视黄醇结合蛋白4、白细胞介素-6、尿N-乙酰-β-D-葡萄糖苷酶数据均低于对照组(P<0.05)。观察组的主要症状、次要症状积分低于对照组(P<0.05)。结论瑞格列奈片联合加味肾气丸治疗阴阳两虚型2型糖尿病患者,可以减轻炎性反应,提升抗氧化、抗纤维化能力,并能够减轻患者症状,对于控制并发症、延缓病情进展有着积极作用,值得推广。

基于双心理论的强心康颗粒+耳穴贴压联合西药治疗慢性心衰合并中重度焦虑临床观察

目的观察强心康颗粒+耳穴贴压联合氟哌噻吨美利曲辛片对慢性心力衰竭(以下简称“心衰”)合并中重度焦虑的疗效。方法纳入合并中重度焦虑[广泛性焦虑量表(GAD-7)测评≥10分]的慢性心衰患者72例,纽约心脏病协会(NYHA)心功能分级Ⅱ~Ⅲ级,分为观察组与对照组,各36例;两组均给予血管紧张素转化酶抑制剂(ACEI)、β受体阻滞剂等心衰基础治疗,观察组给予强心康颗粒+耳穴贴压联合氟哌噻吨美利曲辛片,对照组给予强心康颗粒。观察两组的心功能分级、6 min步行试验、N末端B型脑钠肽原(NT-proBNP)、中医证候评分、GAD-7评分。结果治疗后,两组患者的心功能分级疗效、6 min步行试验、NT-proBNP、中医证候评分、GAD-7评分等指标均较治疗前明显改善,且观察组优于对照组(P<0.05)。结论强心康颗粒+耳穴贴压联合氟哌噻吨美利曲辛片可明显提高慢性心衰合并中重度焦虑患者的临床疗效。

补肾温阳汤治疗卵巢储备功能低下临床研究

目的:观察补肾温阳汤治疗卵巢储备功能低下的临床疗效。方法:将60例卵巢储备功能低下患者按照随机数字表法分为对照组和观察组,每组各30例。对照组给予戊酸雌二醇/雌二醇环丙孕酮片治疗,观察组在对照组治疗的基础上加用补肾温阳汤。比较两组患者的临床疗效以及治疗前后中医证候积分、激素水平[卵泡刺激素(follicle-stimulating hormone,FSH)、雌二醇(estradiol,E_(2))、黄体生成素(luteinizing hormone,LH)、抗米勒管激素(anti mullerian hormone,AMH)]、卵巢功能指标[卵巢体积、卵巢窦卵泡数、卵巢间质动脉收缩期峰值流速(peak systolic velocity,PSV)]变化情况。结果:观察组有效率为93.33%,对照组有效率为73.33%,两组患者有效率比较,差异具有统计学意义(P<0.05)。两组患者治疗后各项中医证候积分低于本组治疗前,且治疗后观察组低于对照组(P<0.05)。两组患者治疗后血清FSH、LH低于本组治疗前,E_(2)高于本组治疗前,且治疗后组间比较,差异具有统计学意义(P<0.05)。两组患者治疗后卵巢窦卵泡数、PSV高于本组治疗前,且治疗后观察组高于对照组(P<0.05)。结论:补肾温阳汤治疗卵巢储备功能低下,可改善患者的临床症状,调节激素水平,促进卵巢功能恢复。

疏肝理气活血汤联合常规西药治疗慢性萎缩性胃炎临床研究

目的:观察疏肝理气活血汤联合常规西药治疗肝胃不和型慢性萎缩性胃炎(CAG)的临床疗效。方法:选择肝胃不和型CAG患者80例,按照随机数字表法分为观察组和对照组各40例。对照组给予枸橼酸莫沙必利片和瑞巴派特片治疗,观察组在对照组基础上加用疏肝理气活血汤治疗。评价2组临床疗效,比较2组治疗前后中医证候积分及病理检查评分,统计不良反应发生率。结果:观察组总有效率为85.00%,高于对照组70.00%(P<0.05)。治疗后,2组中医证候积分较治疗前下降(P<0.05),且观察组中医证候积分低于对照组(P<0.05)。治疗后,2组胃黏膜萎缩、肠上皮化生、异型增生评分较治疗前下降(P<0.05);且观察组胃黏膜萎缩、肠上皮化生、异型增生评分低于对照组(P<0.05)。观察组不良反应发生率低于对照组(P<0.05)。结论:疏肝理气活血汤联合常规西药治疗CAG可改善患者的临床症状,对于缓解或逆转胃黏膜萎缩、肠上皮化生和异型增生具有一定的治疗效果,且不良反应较少。

多孔中药固体片剂孔隙率的太赫兹有效介质模型研究

目前对中药片剂的孔隙测量,一般采用的是具有破坏性的密度测量方法,缺乏无损量化方法。太赫兹辐射能用于无损的提取药物若干光学信息。针对直压型中药片剂,通过太赫兹时域和频域信号处理等不同方法分别计算各种片剂的有效折射率,发现两种方法得到的有效折射率和片剂的孔隙率均呈良好的线性关系。根据有效折射率特性,利用四种有效介质模型提取了中药片剂的孔隙率并进行量化回归,通过交叉验证与相对分析误差(RPD)发现通过时域信号处理的有效折射率得到的孔隙率回归模型解释性与验证准确性更高,其中最佳模型是Bruggeman模型(RPD=11.3325)。为中药多孔粉体制剂工艺优化提供支持。

消风宣窍汤联合氯雷他定片治疗过敏性鼻炎临床研究

目的:观察消风宣窍汤联合氯雷他定片治疗过敏性鼻炎的临床疗效。方法:选取102例过敏性鼻炎患者为研究对象,按随机数字表法分入治疗组与对照组各51例。对照组给予氯雷他定片治疗,治疗组采用消风宣窍汤联合氯雷他定片治疗。比较2组治疗前后中医证候积分、血清免疫球蛋白E (IgE)和炎性因子水平,比较2组临床疗效与不良反应。结果:治疗组总有效率96.08%,高于对照组82.35%(P<0.05)。治疗后,2组鼻塞、黏性和脓性鼻涕、头面部胀痛、嗅觉减退或丧失等中医证候积分均降低(P<0.05),且治疗组低于对照组(P<0.05)。治疗后,2组IgE、白细胞介素-4 (IL-4)、白细胞介素-6 (IL-6)及白细胞介素-10 (IL-10)水平均降低(P<0.05),且治疗组低于对照组(P<0.05)。2组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:消风宣窍汤联合氯雷他定片能提高过敏性鼻炎患者的临床疗效,改善鼻炎症状和免疫功能,降低炎症因子,且不增加不良反应。

固本安胎汤联合地屈孕酮片治疗复发性流产临床研究

目的:观察固本安胎汤联合地屈孕酮片治疗复发性流产(RSA)的临床疗效。方法:选取100例脾肾两虚型RSA患者,按就诊顺序抽签法随机分为2组各50例。对照组给予地屈孕酮片治疗,研究组给予地屈孕酮片联合固本安胎汤治疗。比较2组临床疗效、用药安全性和妊娠结局,并比较2组治疗前后孕激素水平、中医证候评分。结果:研究组总有效率94.00%,高于对照组78.00%(P<0.05)。治疗后,2组中医证候评分均较治疗前降低(P<0.05),且研究组低于对照组(P<0.05)。治疗后,2组血清孕酮、雌二醇、绒毛膜促性腺激素水平均较治疗前升高(P<0.05),且研究组各项指标均高于对照组(P<0.05)。2组用药至妊娠12周,肝肾功能检查和血、尿、便常规检查均无异常。研究组28周妊娠率高于对照组(P<0.05)。结论:固本安胎汤与地屈孕酮片联合可以改善脾肾两虚型RSA患者孕激素水平及妊娠结局,效果较好,用药安全性高。

妇科千金片联合甲硝唑治疗子宫内膜炎的临床效果

目的探究妇科千金片联合甲硝唑在子宫内膜炎患者中的应用效果。方法选取2021年5月至2023年5月宜春市妇幼保健院收治的84例子宫内膜炎患者作为研究对象,按照随机数字表法将其将分为对照组和观察组,每组各42例。对照组患者服用甲硝唑,观察组患者在对照组的基础上加服妇科千金片。比较两组患者的临床疗效、中医证候积分、月经情况、子宫内膜厚度、炎症因子[白介素-2(IL-2)、肿瘤坏死因子-α(TNF-α)、白介素-1β(IL-1β)]、不良反应。结果观察组患者的治疗总有效率高于对照组,差异有统计学意义(P<0.05)。两组患者治疗前的中医证候积分、子宫内膜厚度、炎症因子水平比较,差异无统计学意义(P>0.05);两组患者治疗后的中医证候积分、IL-1β、TNF-α水平均低于治疗前,IL-2水平、子宫内膜厚度高于治疗前,且观察组患者治疗后的中医证候积分、IL-1β、TNF-α水平低于对照组,IL-2水平、子宫内膜厚度高于对照组,差异有统计学意义(P<0.05)。观察组经期正常、经量正常患者多于对照组,不规则出血患者少于对照组,差异有统计学意义(P<0.05)。两组患者的不良反应总发生率比较,差异无统计学意义(P>0.05)。结论子宫内膜炎患者采用妇科千金片与甲硝唑联合治疗效果显著,利于减轻患者临床症状,改善患者月经情况及子宫内膜厚度,减轻炎症反应,且安全性较高,值得推广应用。

通魄汤加减联合多库酯钠片治疗中老年习惯性便秘的临床效果

目的:观察通魄汤加减联合多库酯钠片治疗中老年习惯性便秘的临床效果。方法:选取2021年6月—2022年12月中国人民解放军陆军第七十三集团军医院中医康复理疗科收治的84例中老年习惯性便秘患者,采用随机数表法将其分为两组,各42例。对照组采取多库酯钠片治疗;观察组采取通魄汤加减联合多库酯钠片治疗。对比两组患者治疗前后的中医症状积分、总积分、生活质量评分、临床疗效和不良反应发生情况。结果:治疗前,两组中医症状积分、总积分和生活质量评分比较,差异无统计学意义(P>0.05);治疗后,两组中医症状积分、总积分和生活质量评分均有所改善,而且观察组的中医症状积分(排便时间除外)、总积分和生活质量评分均低于对照组,差异有统计学意义(P<0.05)。观察组总有效率高于对照组,不良反应发生率低于对照组,差异有统计学意义(P<0.05)。结论:通魄汤加减联合多库酯钠片能够显著地改善中老年习惯性便秘患者的临床症状,预后更好。

推拿治疗儿童注意缺陷多动障碍临床疗效观察

目的:观察推拿治疗儿童注意缺陷多动障碍(ADHD)的临床疗效。方法:选取60例ADHD患儿随机分为治疗组(30例)和对照组(30例)。治疗组接受小儿推拿疗法,对照组口服盐酸哌甲酯控释片治疗。比较两组患儿中医证候量表评分、注意缺陷多动障碍筛查量表(SNAP-Ⅳ)评分和临床有效率。结果:治疗后,两组各项评分均低于治疗前,差异有统计学意义(P<0.05)。治疗组中医证候和SNAP-Ⅳ评分均低于对照组,组间比较差异有统计学意义(P<0.05)。治疗组总有效率为80%,对照组为73%,治疗组疗效优于对照组。结论:小儿推拿疗法能够有效控制ADHD患儿多动不安、急躁不宁等症状,与药物相比更加舒适安全且无明显不良反应,在临床中值得应用。